BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 33704931)

  • 1. Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study.
    Numata S; Nakataki M; Hasegawa N; Takaesu Y; Takeshima M; Onitsuka T; Nakamura T; Edagawa R; Edo H; Miura K; Matsumoto J; Yasui-Furukori N; Kishimoto T; Hori H; Tsuboi T; Yasuda Y; Furihata R; Muraoka H; Ochi S; Nagasawa T; Kyou Y; Murata A; Katsumoto E; Ohi K; Hishimoto A; Inada K; Watanabe K; Hashimoto R
    Neuropsychopharmacol Rep; 2021 Jun; 41(2):199-206. PubMed ID: 33704931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.
    Takaesu Y; Watanabe K; Numata S; Iwata M; Kudo N; Oishi S; Takizawa T; Nemoto K; Yasuda Y; Tagata H; Tsuboi T; Tsujino N; Hashimoto N; Matsui Y; Hori H; Yamamori H; Sugiyama N; Suwa T; Kishimoto T; Hishimoto A; Usami M; Furihata R; Iwamoto K; Fujishiro H; Nakamura T; Mizuno K; Inagaki T; Katsumoto E; Tomita H; Ohi K; Muraoka H; Atake K; Iida H; Nagasawa T; Fujita J; Yamamura S; Onitsuka T; Murata A; Takayanagi Y; Noda H; Matsumura Y; Takezawa K; Iga JI; Ichihashi K; Ogasawara K; Yamada H; Inada K; Hashimoto R
    Psychiatry Clin Neurosci; 2019 Oct; 73(10):642-648. PubMed ID: 31437336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study.
    Nakamura T; Furihata R; Hasegawa N; Kodaka F; Muraoka H; Ichihashi K; Ochi S; Numata S; Tsuboi T; Makinodan M; Iida H; Onitsuka T; Kashiwagi H; Takeshima M; Hashimoto N; Nagasawa T; Usami M; Yamagata H; Takaesu Y; Miura K; Matsumoto J; Ohi K; Yamada H; Hori H; Inada K; Watanabe K; Hashimoto R; Yasui-Furukori N
    BMC Psychiatry; 2024 May; 24(1):399. PubMed ID: 38807065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry.
    Ogasawara K; Numata S; Hasegawa N; Nakataki M; Makinodan M; Ohi K; Takeshima M; Tsuboi T; Hashimoto N; Onitsuka T; Muraoka H; Hori H; Ichihashi K; Inagaki T; Yasui-Furukori N; Hishimoto A; Sugiyama N; Fukumoto K; Nagasawa T; Matsumoto J; Takaesu Y; Furihata R; Nemoto K; Nakamura T; Usami M; Miura K; Fujimoto M; Tagata H; Yamada H; Komatsu H; Ochi S; Atake K; Katsumoto E; Kido M; Kishimoto T; Suwa T; Yamamura S; Iga JI; Iida H; Inada K; Watanabe K; Hashimoto R
    Neuropsychopharmacol Rep; 2022 Jun; 42(2):221-225. PubMed ID: 35272393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project.
    Yamada H; Motoyama M; Hasegawa N; Miura K; Matsumoto J; Ohi K; Yasui-Furukori N; Numata S; Takeshima M; Sugiyama N; Nagasawa T; Kubota C; Atake K; Tsuboi T; Ichihashi K; Hashimoto N; Inagaki T; Takaesu Y; Iga JI; Hori H; Onitsuka T; Komatsu H; Hishimoto A; Fukumoto K; Fujimoto M; Nakamura T; Nemoto K; Furihata R; Yamamura S; Yamagata H; Ogasawara K; Katsumoto E; Murata A; Iida H; Ochi S; Makinodan M; Kido M; Kishimoto T; Yasuda Y; Usami M; Suwa T; Inada K; Watanabe K; Hashimoto R
    BJPsych Open; 2022 Apr; 8(3):e83. PubMed ID: 35446248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study.
    Hasegawa N; Yasuda Y; Yasui-Furukori N; Yamada H; Hori H; Ichihashi K; Takaesu Y; Iida H; Muraoka H; Kodaka F; Iga JI; Hashimoto N; Ogasawara K; Ohi K; Fukumoto K; Numata S; Tsuboi T; Usami M; Hishimoto A; Furihata R; Kishimoto T; Nakamura T; Katsumoto E; Ochi S; Nagasawa T; Atake K; Kubota C; Komatsu H; Yamagata H; Ide K; Takeshima M; Kido M; Kikuchi S; Okada T; Matsumoto J; Miura K; Shimazu T; Inada K; Watanabe K; Hashimoto R
    Psychiatry Clin Neurosci; 2023 Oct; 77(10):559-568. PubMed ID: 37684711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the "Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)" project.
    Iida H; Okada T; Nemoto K; Hasegawa N; Numata S; Ogasawara K; Miura K; Matsumoto J; Hori H; Iga JI; Ichihashi K; Hashimoto N; Yamada H; Ohi K; Yasui-Furukori N; Fukumoto K; Tsuboi T; Usami M; Furihata R; Takaesu Y; Hishimoto A; Muraoka H; Katsumoto E; Nagasawa T; Ochi S; Komatsu H; Kikuchi S; Takeshima M; Onitsuka T; Tamai S; Kubota C; Inada K; Watanabe K; Kawasaki H; Hashimoto R
    Neuropsychopharmacol Rep; 2023 Mar; 43(1):23-32. PubMed ID: 36444167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project.
    Hashimoto N; Yasui-Furukori N; Hasegawa N; Ishikawa S; Numata S; Hori H; Iida H; Ichihashi K; Furihata R; Murata A; Tsuboi T; Takeshima M; Kyou Y; Komatsu H; Kubota C; Ochi S; Takaesu Y; Usami M; Nagasawa T; Hishimoto A; Miura K; Matsumoto J; Ohi K; Yamada H; Inada K; Watanabe K; Shimoda K; Hashimoto R
    Asian J Psychiatr; 2021 Sep; 63():102744. PubMed ID: 34325252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project.
    Ichihashi K; Kyou Y; Hasegawa N; Yasui-Furukori N; Shimizu Y; Hori H; Hashimoto N; Ide K; Imamura Y; Yamada H; Ochi S; Iga JI; Takaesu Y; Ohi K; Tsuboi T; Iida H; Yamagata H; Hishimoto A; Horai T; Usami M; Makinodan M; Nagasawa T; Komatsu H; Kido M; Muraoka H; Atake K; Takeshima M; Kubota C; Inagaki T; Tamai S; Kishimoto T; Furihata R; Matsumoto J; Miura K; Inada K; Watanabe K; Kasai K; Hashimoto R
    Asian J Psychiatr; 2022 Mar; 69():103007. PubMed ID: 35051727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of a clinical practice guideline for schizophrenia in a specialist mental health center: an observational study.
    Fischler I; Riahi S; Stuckey MI; Klassen PE
    BMC Health Serv Res; 2016 Aug; 16(a):372. PubMed ID: 27514778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription patterns in patients with schizophrenia in Japan: First-quality indicator data from the survey of "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" project.
    Ichihashi K; Hori H; Hasegawa N; Yasuda Y; Yamamoto T; Tsuboi T; Iwamoto K; Kishimoto T; Horai T; Yamada H; Sugiyama N; Nakamura T; Tsujino N; Nemoto K; Oishi S; Usami M; Katsumoto E; Yamamori H; Tomita H; Suwa T; Furihata R; Inagaki T; Fujita J; Onitsuka T; Miura K; Matsumoto J; Ohi K; Matsui Y; Takaesu Y; Hashimoto N; Iga J; Ogasawara K; Yamada H; Watanabe K; Inada K; Hashimoto R
    Neuropsychopharmacol Rep; 2020 Sep; 40(3):281-286. PubMed ID: 32602667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the "Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)" project.
    Kyou Y; Yasui-Furukori N; Hasegawa N; Ide K; Ichihashi K; Hashimoto N; Hori H; Shimizu Y; Imamura Y; Muraoka H; Iida H; Ohi K; Yasuda Y; Ogasawara K; Numata S; Iga JI; Tsuboi T; Ochi S; Kodaka F; Furihata R; Onitsuka T; Makinodan M; Komatsu H; Takeshima M; Kubota C; Hishimoto A; Atake K; Yamagata H; Kido M; Nagasawa T; Usami M; Kishimoto T; Kikuchi S; Matsumoto J; Miura K; Yamada H; Watanabe K; Inada K; Hahimoto R
    Ann Gen Psychiatry; 2022 Dec; 21(1):52. PubMed ID: 36567327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unmet needs of patients with major depressive disorder - Findings from the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.
    Iida H; Iga J; Hasegawa N; Yasuda Y; Yamamoto T; Miura K; Matsumoto J; Murata A; Ogasawara K; Yamada H; Hori H; Ichihashi K; Hashimoto N; Ohi K; Yasui-Furukori N; Tsuboi T; Nakamura T; Usami M; Furihata R; Takaesu Y; Iwamoto K; Sugiyama N; Kishimoto T; Tsujino N; Yamada H; Hishimoto A; Nemoto K; Atake K; Muraoka H; Katsumoto E; Oishi S; Inagaki T; Ito F; Imamura Y; Kido M; Nagasawa T; Numata S; Ochi S; Iwata M; Yamamori H; Fujita J; Onitsuka T; Yamamura S; Makinodan M; Fujimoto M; Takayanagi Y; Takezawa K; Komatsu H; Fukumoto K; Tamai S; Yamagata H; Kubota C; Horai T; Inada K; Watanabe K; Kawasaki H; Hashimoto R
    Psychiatry Clin Neurosci; 2020 Dec; 74(12):667-669. PubMed ID: 32881226
    [No Abstract]   [Full Text] [Related]  

  • 14. Curricula for teaching clinical practice guidelines in US psychiatry residency and child and adolescent fellowship programs: a survey study.
    Bannister E; Nakonezny P; Byerly M
    Acad Psychiatry; 2014 Apr; 38(2):198-204. PubMed ID: 24619912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to improve the dissemination of clinical practice guidelines in the Brazilian Unified Health System? Report of a pilot project.
    Pereira VC; Silva SN; Vidal ÁT; Lins GVE; Barreto JOM
    Health Res Policy Syst; 2023 Mar; 21(1):22. PubMed ID: 36959620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissemination and implementation of the Royal Australian and New Zealand College of Psychiatrists' clinical practice guidelines.
    Codyre D; Wilson A; Begg J; Barton D
    Australas Psychiatry; 2008 Oct; 16(5):336-9. PubMed ID: 18671142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acupuncture for major depressive disorder: A review of the recommendations stated at clinical practice guidelines.
    Fernandez-Chinguel JE; Goicochea-Lugo S; Villarreal-Zegarra D; Taype-Rondan A; Zafra-Tanaka JH
    Complement Ther Med; 2020 Mar; 49():102321. PubMed ID: 32147048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appraising Otolaryngology-Head and Neck Surgery Clinical Practice Guidelines for Effective Dissemination and Implementation Design.
    Flynn JP; Villwock JA; Chiu AG; Sykes KJ
    Otolaryngol Head Neck Surg; 2020 Aug; 163(2):209-215. PubMed ID: 32125940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indian Psychiatric Society Survey on Clinical Practice Guidelines.
    Grover S; Avasthi A
    Indian J Psychiatry; 2017 Jan; 59(Suppl 1):S10-S18. PubMed ID: 28216782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Review of Clinical Practice Guidelines for Failed Antidepressant Treatment Response in Major Depressive Disorder, Dysthymia, and Subthreshold Depression in Adults.
    MacQueen G; Santaguida P; Keshavarz H; Jaworska N; Levine M; Beyene J; Raina P
    Can J Psychiatry; 2017 Jan; 62(1):11-23. PubMed ID: 27554483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.